These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
492 related articles for article (PubMed ID: 25102364)
1. Potentiation of anthrax vaccines using protective antigen-expressing viral replicon vectors. Wang HC; An HJ; Yu YZ; Xu Q Immunol Lett; 2015 Feb; 163(2):206-13. PubMed ID: 25102364 [TBL] [Abstract][Full Text] [Related]
2. A plant based protective antigen [PA(dIV)] vaccine expressed in chloroplasts demonstrates protective immunity in mice against anthrax. Gorantala J; Grover S; Goel D; Rahi A; Jayadev Magani SK; Chandra S; Bhatnagar R Vaccine; 2011 Jun; 29(27):4521-33. PubMed ID: 21504775 [TBL] [Abstract][Full Text] [Related]
3. Protection of mice against challenge with Bacillus anthracis STI spores after DNA vaccination. Hahn UK; Alex M; Czerny CP; Böhm R; Beyer W Int J Med Microbiol; 2004 Jul; 294(1):35-44. PubMed ID: 15293452 [TBL] [Abstract][Full Text] [Related]
4. Enhancement of antibody responses to Bacillus anthracis protective antigen domain IV by use of calreticulin as a chimeric molecular adjuvant. Park YS; Lee JH; Hung CF; Wu TC; Kim TW Infect Immun; 2008 May; 76(5):1952-9. PubMed ID: 18285494 [TBL] [Abstract][Full Text] [Related]
5. Potentiation of an anthrax DNA vaccine with electroporation. Luxembourg A; Hannaman D; Nolan E; Ellefsen B; Nakamura G; Chau L; Tellez O; Little S; Bernard R Vaccine; 2008 Sep; 26(40):5216-22. PubMed ID: 18462850 [TBL] [Abstract][Full Text] [Related]
6. Combinations of various CpG motifs cloned into plasmid backbone modulate and enhance protective immunity of viral replicon DNA anthrax vaccines. Yu YZ; Ma Y; Xu WH; Wang S; Sun ZW Med Microbiol Immunol; 2015 Aug; 204(4):481-91. PubMed ID: 25265876 [TBL] [Abstract][Full Text] [Related]
8. A cationic lipid-formulated plasmid DNA vaccine confers sustained antibody-mediated protection against aerosolized anthrax spores. Hermanson G; Whitlow V; Parker S; Tonsky K; Rusalov D; Ferrari M; Lalor P; Komai M; Mere R; Bell M; Brenneman K; Mateczun A; Evans T; Kaslow D; Galloway D; Hobart P Proc Natl Acad Sci U S A; 2004 Sep; 101(37):13601-6. PubMed ID: 15342913 [TBL] [Abstract][Full Text] [Related]
9. Protection against anthrax lethal toxin challenge by genetic immunization with a plasmid encoding the lethal factor protein. Price BM; Liner AL; Park S; Leppla SH; Mateczun A; Galloway DR Infect Immun; 2001 Jul; 69(7):4509-15. PubMed ID: 11401993 [TBL] [Abstract][Full Text] [Related]
10. Protective antigen and extractable antigen 1 based chimeric protein confers protection against Bacillus anthracis in mouse model. Makam SS; Kingston JJ; Harischandra MS; Batra HV Mol Immunol; 2014 May; 59(1):91-9. PubMed ID: 24513572 [TBL] [Abstract][Full Text] [Related]
11. Generation of protective immune response against anthrax by oral immunization with protective antigen plant-based vaccine. Gorantala J; Grover S; Rahi A; Chaudhary P; Rajwanshi R; Sarin NB; Bhatnagar R J Biotechnol; 2014 Apr; 176():1-10. PubMed ID: 24548460 [TBL] [Abstract][Full Text] [Related]
12. Immunization with a Recombinant, Pseudomonas fluorescens-Expressed, Mutant Form of Bacillus anthracis-Derived Protective Antigen Protects Rabbits from Anthrax Infection. Reed MD; Wilder JA; Mega WM; Hutt JA; Kuehl PJ; Valderas MW; Chew LL; Liang BC; Squires CH PLoS One; 2015; 10(7):e0130952. PubMed ID: 26207820 [TBL] [Abstract][Full Text] [Related]
13. Multiagent vaccines vectored by Venezuelan equine encephalitis virus replicon elicits immune responses to Marburg virus and protection against anthrax and botulinum neurotoxin in mice. Lee JS; Groebner JL; Hadjipanayis AG; Negley DL; Schmaljohn AL; Welkos SL; Smith LA; Smith JF Vaccine; 2006 Nov; 24(47-48):6886-92. PubMed ID: 16828936 [TBL] [Abstract][Full Text] [Related]
14. [Immunogenicity of the recombinant Bacillus strains with cloned gene of biosynthesis of protective antigen against Bacillus anthracis]. Mikshis NI; Kudriavtseva OM; Bolothikova MF; Shulepov DV; Novikova LV; Popov IuA; Shchukovskaia TN; Drozdov IG; Kutyrev VV Mol Gen Mikrobiol Virusol; 2007; (3):15-21. PubMed ID: 17886469 [TBL] [Abstract][Full Text] [Related]
15. Selection and evaluation of the immunogenicity of protective antigen mutants as anthrax vaccine candidates. Yan M; Roehrl MH; Basar E; Wang JY Vaccine; 2008 Feb; 26(7):947-55. PubMed ID: 18192092 [TBL] [Abstract][Full Text] [Related]
16. Immunogenicity and efficacy of an anthrax/plague DNA fusion vaccine in a mouse model. Albrecht MT; Eyles JE; Baillie LW; Keane-Myers AM FEMS Immunol Med Microbiol; 2012 Aug; 65(3):505-9. PubMed ID: 22515653 [TBL] [Abstract][Full Text] [Related]
17. Anthrax protective antigen administered by DNA vaccination to distinct subcellular locations potentiates humoral and cellular immune responses. Midha S; Bhatnagar R Eur J Immunol; 2009 Jan; 39(1):159-77. PubMed ID: 19130551 [TBL] [Abstract][Full Text] [Related]
18. Trimethyl Chitosan Nanoparticles Encapsulated Protective Antigen Protects the Mice Against Anthrax. Malik A; Gupta M; Mani R; Gogoi H; Bhatnagar R Front Immunol; 2018; 9():562. PubMed ID: 29616046 [TBL] [Abstract][Full Text] [Related]
19. A novel live attenuated anthrax spore vaccine based on an acapsular Bacillus anthracis Sterne strain with mutations in the htrA, lef and cya genes. Chitlaru T; Israeli M; Rotem S; Elia U; Bar-Haim E; Ehrlich S; Cohen O; Shafferman A Vaccine; 2017 Oct; 35(44):6030-6040. PubMed ID: 28342664 [TBL] [Abstract][Full Text] [Related]
20. Comparative performance of a licensed anthrax vaccine versus electroporation based delivery of a PA encoding DNA vaccine in rhesus macaques. Livingston BD; Little SF; Luxembourg A; Ellefsen B; Hannaman D Vaccine; 2010 Jan; 28(4):1056-61. PubMed ID: 19896452 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]